Concepedia

Taru Hallinen

TH

Statistics

Publications

18

Citations

473

H-Index

16

Active since

2004

Affiliations

ESiOR Oy (Finland)(Current)

Helsinki University Hospital

Kuopio University Hospital

University of Eastern Finland

Päijät-Hämeen Keskussairaala

Taru Hallinen is an author at ESiOR Oy (Finland) specializing in cost-effectiveness analysis, pharmacoeconomics, and pharmacy.

Publications per year

2004–2023

18

Publications

18

Cost-utility of different treatment strategies after the failure of tumour necrosis factor inhibitor in rheumatoid arthritis in the Finnish setting

Taru Hallinen, Erkki Soini, Kari K. Eklund et al. · Lara D. Veeken · 2010 · 57 citations · Full text

, , +16

Cost-effectiveness of adalimumab, etanercept, and tocilizumab as first-line treatments for moderate-to-severe rheumatoid arthritis

Erkki Soini, Taru Hallinen, Kari Puolakka et al. · Journal of Medical Economics · 2011 · 51 citations

, , +15

Ustekinumab for Crohn’s disease: a nationwide real-life cohort study from Finland (FINUSTE)

Anja Eberl, Taru Hallinen, Clas-Göran af Björkesten et al. · Scandinavian Journal of Gastroenterology · 2019 · 48 citations · Full text

, , +17

Cost–Utility of First-Line Actinic Keratosis Treatments in Finland

Erkki Soini, Taru Hallinen, Anna-Leena Sokka et al. · Advances in Therapy · 2015 · 31 citations · Full text

, , +17

Economic Evaluation of Temozolomide in the Treatment of Recurrent Glioblastoma Multiforme

Janne Martikainen, Akseli Kivioja, Taru Hallinen et al. · PharmacoEconomics · 2005 · 30 citations

, , +13

1–5 of 18